Table 2. Univariate Survival Analysis by Kaplan-Meier.
| Items | 5-Year Survival | 10-Year Survival | P-Value |
|---|---|---|---|
| Whole survival | 92.7% | 85.1% | |
| Age (Years) | |||
| 0–20 | 50% | 0.017 | |
| 21–40 | 95% | 88.5% | |
| 41–60 | 92.3% | ||
| 61–80 | 84.3% | ||
| Gender | |||
| Men | 95.5% | 0.55 | |
| Women | 89.9% | 85.0% | |
| Eye | |||
| Right | 92.9% | 87.7% | 0.58 |
| Left | 92.5% | ||
| Visual Acuity (Decimal) | |||
| <0.1 | 95.6% | 0.50 | |
| 0.1–0.49 | 94.1% | ||
| 0.5–079 | |||
| ≥0.8 | 96.0% | ||
| Intraocular Pressure (mm Hg) | |||
| <10mmHg | 0.44 | ||
| 10–21 | 94.9% | ||
| >21mmHg | |||
| Retinal Detachment | |||
| Yes | 97.2% | 0.62 | |
| Tumor Position | |||
| superior | 95.5% | 0.004 | |
| nasal | 98.1% | ||
| inferior | 83.3% | ||
| temporal | 85.3% | ||
| superior temporal | 96.8% | ||
| superior nasal | 93.8% | ||
| inferior nasal | 91.1% | ||
| inferior temporal | 95.9% | ||
| diffuse | 53.3% | ||
| Tumor Location | |||
| ciliary body | 97% | 0.90 | |
| iris | |||
| choroid | 92.6% | 84.2% | |
| Optic Disc Involvement | |||
| no | 92.6% | 84.8% | |
| Tumor Size | |||
| Small | <0.001 | ||
| medium | 96.5% | ||
| large | 83.9% | ||
| Tumor Shape | |||
| mushroom | 95.2% | 0.025 | |
| flat | 83.3% | ||
| hemispheric | 98.2% | ||
| irregular | 87.7% | ||
| Tumor Pathology | |||
| spindle | 91.0% | 0.014 | |
| epitheloid | 67.0% | ||
| mixed | 72.3% | ||
| Treatment | |||
| episcleral brachytherapy(EB) | 98.4% | <0.001 | |
| local resection | 94.8% | 79.2% | |
| primary enucleation | 84.8% | ||
| EB + enucleation | 85.5% | ||
| Initial Treatment | |||
| episcleral brachytherapy(EB) | 95.5% | 0.005 | |
| local resection | 94.8% | 79.2% | |
| primary enucleation | 84.8% |